Sonata Capital Group’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-3,710
Closed -$248K 96
2018
Q3
$248K Hold
3,710
0.17% 95
2018
Q2
$240K Hold
3,710
0.17% 98
2018
Q1
$266K Sell
3,710
-200
-5% -$14.4K 0.2% 90
2017
Q4
$295K Hold
3,910
0.21% 89
2017
Q3
$285K Hold
3,910
0.21% 89
2017
Q2
$290K Hold
3,910
0.22% 84
2017
Q1
$286K Hold
3,910
0.22% 87
2016
Q4
$256K Hold
3,910
0.2% 89
2016
Q3
$290K Hold
3,910
0.24% 82
2016
Q2
$286K Hold
3,910
0.24% 81
2016
Q1
$276K Hold
3,910
0.24% 81
2015
Q4
$260K Hold
3,910
0.23% 85
2015
Q3
$248K Hold
3,910
0.23% 86
2015
Q2
$256K Hold
3,910
0.22% 85
2015
Q1
$271K Hold
3,910
0.24% 82
2014
Q4
$271K Buy
+3,910
New +$264K 0.25% 81

Other funds holding CL

Sonata Capital Group's CL Position: Q4 2018 in Review

Sonata Capital Group sold out of Colgate-Palmolive (CL) in Q4 2018, closing a stake of 3,710 shares — an estimated $248K sold.

Sonata Capital Group first reported a position in CL in Q4 2014 and held it in 16 quarters. The position peaked at $295K in Q4 2017. 1,427 funds tracked by Wall St. Rank hold CL as of Q4 2018.

  • Sonata Capital Group reported no remaining Colgate-Palmolive position as of Q4 2018 after selling out during the quarter.
  • Sonata Capital Group sold 3,710 Colgate-Palmolive shares in Q4 2018, an estimated $248K.
  • Sonata Capital Group first reported a position in Colgate-Palmolive in Q4 2014 and held it in 16 quarters.
  • Sonata Capital Group's Colgate-Palmolive position peaked at $295K in Q4 2017.
  • 1,427 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q4 2018.

Based on Sonata Capital Group's 13F filing for Q4 2018, filed 31 Jan 2019.